L V Rozenshtraukh Selected Research

niferidil

1/2015	[Refralon (niferidil) is a new class III antiarrhythmic agent for pharmacological cardioversion for persistent atrial fibrillation and atrial flutter].
1/2014	[Novel class III antiarrhythmic agent niferidile: review of experimental and clinical studies].
1/2011	[First experience of clinical use of new class III antiarrhythmic agent niferidil in patients with persistent atrial fibrillation and flutter].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L V Rozenshtraukh Research Topics

Disease

11	Atrial Fibrillation 10/2017 - 05/2001
3	Hypothermia 12/2014 - 03/2007
2	Ventricular Tachycardia 01/2014 - 01/2008
2	Torsades de Pointes (Torsade de Pointes) 01/2014 - 01/2008
1	Tachycardia (Tachyarrhythmias) 11/2019
1	Morbid Obesity 10/2017
1	Obesity 10/2017
1	Atrial Flutter (Flutter, Atrial) 01/2015

Drug/Important Bio-Agent (IBA)

3	Anti-Arrhythmia AgentsIBA 10/2017 - 01/2004
3	niferidilIBA 01/2015 - 01/2011
3	Cholinergic Agents (Cholinergics)IBA 01/2003 - 05/2001
2	Adrenergic Agents (Adrenergic Drugs)IBA 11/2019 - 10/2001
2	dimemorfan (AT 17)IBA 12/2014 - 03/2007
2	RyanodineIBA 01/2002 - 05/2001
2	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2001 - 05/2001
1	PotassiumIBA 01/2015
1	Dronedarone FDA Link 01/2010
1	Coloring Agents (Dyes)IBA 05/2009
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2007
1	nibentan (HE 11)IBA 01/2007
1	Verapamil (Calan)FDA LinkGeneric 01/2003
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2002
1	SolutionsIBA 10/2001
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 10/2001

Therapy/Procedure

5	Electric Countershock (Cardioversion) 10/2017 - 01/2007